Celecoxib
- Molecular formula
- C17H14BrF3N3O2S
- CAS Number
- 169590-42-5
- IUPAC Name
- 4-[5-(4-bromophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
- Molecular Weight
- 381.37g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.6950g/cm3
- Synonyms
- 845674-84-2
Identification
Interesting Facts about 4-[5-(4-bromophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
This compound belongs to the class of sulfonamide derivatives, which are known for their wide range of biological activities. Its complex structure features both a pyrazole and a sulfonamide functional group, which plays a crucial role in its biological applications.
Biological Significance
- Pharmacological Potential: Compounds like this one have been studied for their potential as anti-inflammatory and antimicrobial agents.
- Mechanism of Action: The sulfonamide moiety is known to inhibit bacterial growth by interfering with folic acid synthesis.
Structural Components
Examining its structure reveals various functional groups that contribute to its properties:
- Trifluoromethyl Group: This highly electronegative group can influence the compound's lipophilicity and electronic properties.
- Bromophenyl Unit: The presence of the bromine atom can enhance the compound's interactions with biological targets.
- Pyrazole Ring: Known for its stability and ability to form hydrogen bonds, the pyrazole unit increases the molecule's pharmacological activity.
Applications in Research
This compound is not only significant in pharmacology but also serves as a valuable tool in chemical synthesis and materials science:
- Research Chemical: It can be utilized as a precursor in synthetic routes for more complex medicinal compounds.
- Material Science: Due to its unique properties, it could be integrated into developing new materials with desirable characteristics.
As scientists continue to explore its full potential, the compound’s unique combination of structural features and biological relevance highlights the exciting possibilities that sulfonamide derivatives hold in future therapeutic applications.